review Open AccessTop 1% cited
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
Leukemia · 2010 · Vol. 24(6) · pp. 1121–1127
Robert A. Kyle✉(Mayo Clinic in Arizona)Brian G.M. Durie(Cedars-Sinai Medical Center)S. Vincent Rajkumar(Mayo Clinic in Arizona)Ola Landgren(National Cancer Institute)Joan Bladé(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)Giampaolo MerliniNicolaus Kröger(Universität Hamburg)Hermann Einsele(University of Würzburg)David H. Vesole(Hackensack University Medical Center)Meletios Α. Dimopoulos(National and Kapodistrian University of Athens)Jesús F. San Miguel(Centro de Investigación del Cáncer)Hervé Avet‐LoiseauRoman Hájek(University Hospital Brno)W M Chen(Beijing Chaoyang Emergency Medical Center)Kenneth C. Anderson(Dana-Farber Cancer Institute)Heinz Ludwig(Wilhelminen Hospital)Pieter Sonneveld(Erasmus University Rotterdam)S PavlovskyAntonio Palumbo(University of Turin)Paul G. Richardson(Dana-Farber Cancer Institute)Bart BarlogiePatricia T. Greipp(Mayo Clinic)Robert Vescio(Cedars-Sinai Medical Center)Ingemar Turesson(Lund University)Jan Westin(Sahlgrenska University Hospital)Mario Boccadoro(University of Turin)on behalf of the International Myeloma Working Group
Multiple Myeloma Research and TreatmentsAmyloidosis: Diagnosis, Treatment, OutcomesGlycosylation and Glycoproteins ResearchMonoclonal gammopathy of undetermined significanceMultiple myelomaMedicineAsymptomaticSerum protein electrophoresisInternal medicineMacroglobulinemiaAL amyloidosisAmyloidosisWaldenstrom macroglobulinemia
MeSH terms
HumansMonoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaPrognosisRisk FactorsPractice Guidelines as TopicDisease Progression
Citations
860
FWCI
26.86
field-weighted impact
References
24
Percentile
100%
vs. same field & year
Citations per year
Cited by
Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines
Mayo Clinic Proceedings · 2009 · 623 citations
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
The Lancet Oncology · 2014 · 4,761 citations
References
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
British Journal of Haematology · 2003 · 2,306 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.